Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-074496
Filing Date
2025-05-19
Accepted
2025-05-19 16:54:17
Documents
1
Period of Report
2025-05-16

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3030
  Complete submission text file 0000950170-25-074496.txt   4610
Mailing Address 221 CRESCENT ST. BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 23, SUITE 105 WALTHAM MA 02453 (781) 312-3013
Jade Biosciences, Inc. (Issuer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CHINOOK THERAPEUTICS U.S., INC. 1600 FAIRVIEW AVE. E. SEATTLE WA 98102
Business Address
Frohlich Tom (Reporting) CIK: 0001823925 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40544 | Film No.: 25964770